22
Short bowel syndrome Dr. Henrik Csaba Horvath Bible class February 20, 2013

Short bowel syndrome

  • Upload
    rosine

  • View
    101

  • Download
    0

Embed Size (px)

DESCRIPTION

Short bowel syndrome. Dr. Henrik Csaba Horvath. Bible class February 20, 2013. Definition of short-bowel syndrome. Loss of intestinal absorption from surgical resection , congenital defect or diseases characterized by the inability to maintain - PowerPoint PPT Presentation

Citation preview

Page 1: Short  bowel syndrome

Short bowel syndromeDr. Henrik Csaba Horvath

Bible class February 20, 2013

Page 2: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 2

Klinik- bzw. Direktionsname

Definition of short-bowel syndrome

Loss of intestinal absorption from surgical resection,congenital defect or diseases characterized by the inability to maintainprotein-energy, fluid, electrolyte, or micronutrient balances when on aconventionally accepted, normal diet

Page 3: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 3

Klinik- bzw. Direktionsname

Which conditions can lead to a short-bowel syndrome?

Physical loss ofportions of intestine

Loss of function

cObstruction

Dysmotility

Surgicalresection(volvulus)

Congenitaldefect

Disease-associatedloss of absorption

(Crohn`s,postirradiation)

Loss of bowelor enterocyte mass(trauma, infarction)

SBS-associated intestinal failure

Page 4: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 4

Klinik- bzw. Direktionsname

Major causes of SBS in adults?

Postoperative complicationsIrradiaton/cancerMesenteric valvular disease (mesenteric ischemia)Crohn`s diseaseTrauma

Page 5: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 5

Klinik- bzw. Direktionsname

Which factors are associated with worse prognosis in patients with SBS?

Total parenteral nutrition< 50 cm intact bowelEnterostomyRadiation or ischemic enteritis

Page 6: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 6

Klinik- bzw. Direktionsname

Which factors have impact on the outcome of SBS?

Presence/abscence of ileocaecal valve

Outcome of SBS

Length of theremaining intestine

Segment of intact bowel(jejunum vs. ileum, colon continuity)

Absorptive quality ofthe remnant bowel

Presence of residualunderlying disease

(e.g.Crohn`s)

Age/BMI ofthe patient

State of other digestive organs

Efficacy ofnutrition support

Pharmacologic therapy

Page 7: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 7

Klinik- bzw. Direktionsname

How does affect the remnant length the risk of developing SBS?

Anastomosis PLUS length of residual small intestine

Duodenostomy or jejunoileal < 35 cm

Jejunocolic or ileocolic < 60 cm

End jejunostomy < 115 cm

Patients at highest risk of developing SBS are

Page 8: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 8

Klinik- bzw. Direktionsname

Which impact has on absorption the resection of…

Loss of the major intestinal absorption areaLoss of digestive enzymesLoss of GI feedback hormones (gastric emptying)

Jejunum:

Ileum:

Loss of the absorption of jejunal secretion Loss of absorption of vitamin B12

Loss of absorption of bile salts (fat malabsorption)

Page 9: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 9

Klinik- bzw. Direktionsname

Which impact has the loss of ileocaecal valve?

Dilatation of the small intestineSlower motility

Bacterial overgrowth of the small intestine

Competition for nutrients,inflammation, GI bleeding,bacterial translocation ± endotoxaemia,liver injury, D-lactic acidosis

Page 10: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 10

Klinik- bzw. Direktionsname

Which adaptive mechanisms occur in the residual intestine/ GI tract?

Mucosal hyperplasia (due to fat stimulated glucagon-like peptide receptor II)Increased mucosal blood flowImproved segmental absorption

Gastric hypersecretionIncreased pancreatobiliary secretions

Up to 70% can do without TPN due to these mechanisms

Page 11: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 11

Klinik- bzw. Direktionsname

Importance of colon in compensation for the lack of intestine?

Increase reabsorption of water, electrolytes, short-chain fatty acids and GI secretions

Slow down the intestinal transit and stimulate intestinal adaptation by hormonal regulation

Fermentation of malabsorbed carbohydrates by colonic bacteria

Page 12: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 12

Klinik- bzw. Direktionsname

Measurement of the functional capacity of the small intestine?

1. 48-hour nutritional balance test analysis of daily absorption rate (intake-output)

prediction of intestinal failure: <1,4 kg wet weight/day 1170 kcal/day of energy

(Difficulties with duplicate food portions and accurate stool collections)

2. Fasting plasma citrulline concentration (>5 μmol/L)(is synthetized by the small intestine, best practical measure of enterocyte function)

Page 13: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 13

Klinik- bzw. Direktionsname

Two major groups of complications of SBS?

dehydrationelectrolyte derangements (Mg, Ca, K)

Diagnosis: urinary electrolyte levels (plasma can be normal!)Treatment: sustained correction due to slow cellular uptake

TPN-relatedbacterial overgrowthmicronutrient deficiencymetabolic

Early complications:

Late complications:

Page 14: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 14

Klinik- bzw. Direktionsname

TPN-related late complications of SBS are…

gallstones, cirrhosis (IFALD)

end-stage liver cirrhosis in 15% of pts after one year TPN100% mortality rate within 2 yrs

infection: one-third of deaths in 50% 5-yr-mortality rate in SBSthrombosis (v. cava superior): 0.2/1000 catheter days

1. Due to bypass first pass liver metabolism:

2. Catheter-associated complications:

steatosis cholestasis

Page 15: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 15

Klinik- bzw. Direktionsname

Bacterial overgrowth-related late complications of SBS are…

1. carbohydrate malabsorption 2. sepsis due to bacterial localisation

3. decreased absorption of fatty acids due to interference with chilomicron formation

4. loss of absorptive capacity due to inflammatory response

Page 16: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 16

Klinik- bzw. Direktionsname

Which are the most common micronutritient deficiencies as late complications of SBS?

2. fat-soluble vitamins (A,D,E,K)

3. vitamin B12

4. folate

(if >60 cm of terminal ileum resected)

(if proximal jejunum resected)

1. Mg, Ca, Zn, Se

Micronutrients Recommended dose /day

Vitamin A 10.000-50.000 units

Vitamin B12 300 μg/month

Vitamin C 200-500mg

Vitamin D 1600 U

Vitamin E 30 IU

Vitamin K 10 mg/week

Calcium 800-1200 mg

Magnesium As needed

Iron As needed

Selenium 60-100 μg

Zinc 220-440 mg

Bicarbonate As needed

Page 17: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 17

Klinik- bzw. Direktionsname

The most common metabolic complications of small-bowel syndrome?

gram-positive colonic bacteriaferment carbohydrate to D-lactic acid

Acidic environment

short-chain fatty acids

proliferation of the flora

Metabolic acidosis (encephalopathy, headaches, ataxia, dysarthria)

1. Metabolic acidosis2. Hyperoxaliuria (nephrolithiasis, chronic renal failure)3. Hyperammoniaemia4. Metabolic bone disease (osteoporosis, osteomalacia)

Page 18: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 18

Klinik- bzw. Direktionsname

3 key points of management?1. Nutrition / Supplementation of micronutrients2. Maintaining fluid, electrolytes and acid/base balance3. Avoid complications

Calories to be supplied: 25-30 kcal/kg/day

Proteins to be supplied: 1.0-1.5 g/kg/day

40-50% carbohydrates20-30% proteins20-40% lipids

Continous PN

Cyclic/discontinous PN

Continous enteral

Bolus enteral

Intravenous fluid Oral rehidration fluid(glucose-polymer based with sodium)

ORS ±oral electrolyte suppl.

Page 19: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 19

Klinik- bzw. Direktionsname

Pharmacologic adjuncts in the management?

2. loperamid, diphenoxylate, codein: anti-motility agents

3. octreotid: increasing the small bowel transit time (but also inhibits pancreatic secretions) only if > 3 L of iv. fluid intake is required

4. cholestyramine: binding bile salts in steatorrhea secondary to bile acid malabsorption

1. glucagon-like peptide-2 (teglutide): promotion of adaption

Cheng TT et al :Clinical and Experimental Gastroenterology 2011:4 189–196

Page 20: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 20

Klinik- bzw. Direktionsname

Two categories of surgical treatment options?

2. transplant1. non- transplant

1. Preserve intestinal remnantminimize resrection, restore intestinal continuity, recruit additional intestine

2. Slow intestinal transit (segmental reversal of intestine, colonic interposition)

3. Increase intestinal surface (LILT = longitudinal intestinal lengthening and tailoring with longitudinal devision of intestine and blood supply at the mesenteric border) STEP = serial transverse enteroplasty)

Aims of non-transplant surgical treatments?

Page 21: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 21

Klinik- bzw. Direktionsname

Surgical treatment of short bowel syndrome

Indications for intestinal transplants?

1. Impending or overt liver failure (ESLD)2. Thrombosis of major central venous channels3. Frequent central line-related sepsis (>2 episodes/year)4. Frequent severe dehydration5. Diffuse mesenteric venous thrombosis with complications

Page 22: Short  bowel syndrome

Titel der Präsentation / Name Referent/-in 22

Klinik- bzw. Direktionsname

Intestinal transplantation for SBS

Which effect has the combined transplanton the rejection rate of intestinal transplants?

Major complications and cause of death after intestinal transplantation?

Acute and chronic rejection rate is lower in combined transplants(liver+intestine, multivisceral)

Sepsis, MOF, rejection